Articles published by Newman Ferrara LLP
![](https://mms.businesswire.com/media/20231205852813/en/633896/5/NF-Logo.jpg)
![](https://mms.businesswire.com/media/20230110005946/en/633896/5/NF-Logo.jpg)
Newman Ferrara LLP Investigating Officers and Directors of 180 Life Sciences Corp. (ATNF)
January 10, 2023
From Newman Ferrara LLP
Via Business Wire
Tickers
ATNF
![](https://mms.businesswire.com/media/20230110005919/en/633896/5/NF-Logo.jpg)
Newman Ferrara LLP Announces Corporate Governance Investigations of Zentalis Pharmaceuticals, Inc. (ZNTL)
January 10, 2023
From Newman Ferrara LLP
Via Business Wire
Tickers
ZNTL
![](https://mms.businesswire.com/media/20221212005645/en/633896/5/NF-Logo.jpg)
Newman Ferrara LLP Announces Corporate Governance Investigations of Instil Bio, Inc. (TIL)
December 12, 2022
From Newman Ferrara LLP
Via Business Wire
Tickers
TIL
![](https://mms.businesswire.com/media/20221212005642/en/633896/5/NF-Logo.jpg)
Newman Ferrara LLP Announces Corporate Governance Investigations of Sensei Biotherapeutics, Inc. (SNSE)
December 12, 2022
From Newman Ferrara LLP
Via Business Wire
Tickers
SNSE
![](https://mms.businesswire.com/media/20220907006235/en/633896/5/NF-Logo.jpg)
Newman Ferrara LLP Announces Corporate Governance Investigations of Passage Bio, Inc. (PASG)
September 07, 2022
From Newman Ferrara LLP
Via Business Wire
Tickers
PASG
![](https://mms.businesswire.com/media/20220907006236/en/633896/5/NF-Logo.jpg)
Newman Ferrara LLP Announces Corporate Governance Investigations of PTC Therapeutics (PTCT)
September 07, 2022
From Newman Ferrara LLP
Via Business Wire
Tickers
PTCT
![](https://mms.businesswire.com/media/20220907006234/en/633896/5/NF-Logo.jpg)
Newman Ferrara LLP Announces Corporate Governance Investigations of 3M Company (MMM)
September 07, 2022
From Newman Ferrara LLP
Via Business Wire
Tickers
MMM
![](https://mms.businesswire.com/media/20220726005876/en/633896/5/NF-Logo.jpg)
![](https://mms.businesswire.com/media/20220131005932/en/633896/5/NF-Logo.jpg)
Newman Ferrara LLP Announces Corporate Governance Investigation of Sorrento Therapeutics, Inc. – SRNE
January 31, 2022
From Newman Ferrara LLP
Via Business Wire
Tickers
SRNE
![](https://mms.businesswire.com/media/20220131005929/en/1344795/21/Long-Logo.jpg)
Newman Ferrara LLP Announces Corporate Governance Investigation of CME Group Inc. – CME
January 31, 2022
From Newman Ferrara LLP
Via Business Wire
Tickers
CME
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.